Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Mehr anzeigen
AUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data that it is halting its clinical program in rheumatological disease while it seeks to understand the...
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.67 | 17.5853018373 | 3.81 | 4.54 | 3.72 | 78336 | 4.13130285 | CS |
| 4 | -1.87 | -29.4488188976 | 6.35 | 7.24 | 3.51 | 102545 | 5.31329138 | CS |
| 12 | -2.92 | -39.4594594595 | 7.4 | 8.32 | 3.51 | 66568 | 6.25973493 | CS |
| 26 | -1.1 | -19.7132616487 | 5.58 | 8.32 | 3.51 | 61881 | 6.46807437 | CS |
| 52 | 0.43 | 10.6172839506 | 4.05 | 9.96 | 3.51 | 78534 | 6.52699625 | CS |
| 156 | -6.67 | -59.8206278027 | 11.15 | 11.9 | 3 | 63785 | 6.04495445 | CS |
| 260 | -14.16 | -75.9656652361 | 18.64 | 31.85 | 3 | 121700 | 13.98104071 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
